ARCHIVES

Bonadonna’s Study At Four Years: CMF Group Still Doing Better

This article is from The Cancer Letter archive.

Vol. 04 No. 47 | November 24, 1978

Download PDF Visit The Full Archive

Related Articles

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

Other NCI funding opportunities listed.

July 9, 2004

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

Barbara Rimer Named NCAB Chairman; First Women Appointed To Lead Board

September 16, 1994

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998